> top > docs > PMC:7199903 > spans > 15455-16161 > annotations

PMC:7199903 / 15455-16161 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T85 183-195 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925
T86 569-579 Body_part denotes nucleotide http://purl.org/sig/ont/fma/fma82740

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T55 30-38 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T95 48-49 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T96 122-123 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T97 280-281 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T98 530-537 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T154 183-195 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089
T155 302-311 Chemical denotes immunogen http://purl.obolibrary.org/obo/CHEBI_60816
T156 416-422 Chemical denotes Glycan http://purl.obolibrary.org/obo/CHEBI_18154
T157 480-487 Chemical denotes antigen http://purl.obolibrary.org/obo/CHEBI_59132
T158 569-579 Chemical denotes nucleotide http://purl.obolibrary.org/obo/CHEBI_36976
T159 668-677 Chemical denotes immunogen http://purl.obolibrary.org/obo/CHEBI_60816

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T70 72-76 http://purl.obolibrary.org/obo/BFO_0000029 denotes site
T71 488-495 http://purl.obolibrary.org/obo/BFO_0000019 denotes quality

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T53028 0-3 PRP-DOLLAR- denotes Our
T82153 4-17 NN denotes glycosylation
T40708 18-26 NN denotes analysis
T61579 27-29 IN denotes of
T12079 30-40 NN denotes SARS-CoV-2
T49219 41-47 VBZ denotes offers
T94729 48-49 DT denotes a
T57933 50-58 JJ denotes detailed
T74120 59-68 NN denotes benchmark
T48966 69-71 IN denotes of
T58340 72-85 JJ denotes site-specific
T31488 86-92 NN denotes glycan
T43905 93-103 NNS denotes signatures
T84329 104-118 JJ denotes characteristic
T21494 119-121 IN denotes of
T57185 122-123 DT denotes a
T30603 124-132 RB denotes natively
T58151 133-139 VBN denotes folded
T94639 140-148 JJ denotes trimeric
T50255 149-154 NN denotes spike
T49489 156-158 IN denotes As
T30681 159-161 DT denotes an
T53669 162-172 VBG denotes increasing
T65899 173-179 NN denotes number
T82409 180-182 IN denotes of
T8477 183-201 JJ denotes glycoprotein-based
T94196 202-209 NN denotes vaccine
T43282 210-220 NNS denotes candidates
T96948 221-224 VBP denotes are
T96900 225-230 VBG denotes being
T67675 231-240 VBN denotes developed
T62659 240-241 -COMMA- denotes ,
T20755 242-247 PRP-DOLLAR- denotes their
T47361 248-256 JJ denotes detailed
T51541 257-263 NN denotes glycan
T66124 264-272 NN denotes analysis
T40599 273-279 VBZ denotes offers
T90463 280-281 DT denotes a
T34862 282-287 NN denotes route
T97151 288-291 IN denotes for
T93438 292-301 VBG denotes comparing
T16844 302-311 NN denotes immunogen
T61238 312-321 NN denotes integrity
T30860 322-325 CC denotes and
T24785 326-330 MD denotes will
T90065 331-335 RB denotes also
T99893 336-338 VB denotes be
T50945 339-348 JJ denotes important
T69841 349-351 TO denotes to
T90334 352-359 VB denotes monitor
T29169 360-362 IN denotes as
T25038 363-376 NN denotes manufacturing
T2806 377-386 NNS denotes processes
T74292 387-390 VBP denotes are
T70120 391-397 VBN denotes scaled
T94082 398-401 IN denotes for
T25098 402-410 JJ denotes clinical
T10017 411-414 NN denotes use
T12304 416-422 NN denotes Glycan
T79926 423-432 NN denotes profiling
T48513 433-437 MD denotes will
T46336 438-447 RB denotes therefore
T92867 448-452 RB denotes also
T57413 453-455 VB denotes be
T41872 456-458 DT denotes an
T99603 459-468 JJ denotes important
T40050 469-476 NN denotes measure
T31145 477-479 IN denotes of
T69406 480-487 NN denotes antigen
T71732 488-495 NN denotes quality
T75814 496-498 IN denotes in
T39084 499-502 DT denotes the
T83900 503-514 NN denotes manufacture
T63349 515-517 IN denotes of
T35288 518-529 JJ denotes serological
T45219 530-537 NN denotes testing
T20226 538-542 NNS denotes kits
T63904 544-548 JJ denotes Last
T97760 548-549 -COMMA- denotes ,
T65795 550-554 IN denotes with
T65559 555-558 DT denotes the
T81020 559-565 NN denotes advent
T37516 566-568 IN denotes of
T28720 569-585 JJ denotes nucleotide-based
T21690 586-594 NNS denotes vaccines
T20374 594-595 -COMMA- denotes ,
T66422 596-598 PRP denotes it
T36320 599-603 MD denotes will
T53107 604-606 VB denotes be
T18553 607-616 JJ denotes important
T20438 617-619 TO denotes to
T43342 620-630 VB denotes understand
T90541 631-634 WRB denotes how
T45086 635-640 DT denotes those
T83637 641-649 NN denotes delivery
T13791 650-660 NNS denotes mechanisms
T62450 661-667 VBP denotes affect
T67741 668-677 NN denotes immunogen
T75860 678-688 NN denotes processing
T3133 689-692 CC denotes and
T84057 693-705 NN denotes presentation
R47296 T74120 T48966 arg1Of benchmark,of
R53689 T43905 T48966 arg2Of signatures,of
R21113 T43905 T58340 arg1Of signatures,site-specific
R49627 T43905 T31488 arg1Of signatures,glycan
R85112 T43905 T84329 arg1Of signatures,characteristic
R76705 T84329 T21494 arg1Of characteristic,of
R27530 T50255 T21494 arg2Of spike,of
R74427 T50255 T57185 arg1Of spike,a
R8945 T58151 T30603 arg1Of folded,natively
R10308 T50255 T58151 arg1Of spike,folded
R97285 T50255 T94639 arg1Of spike,trimeric
R20765 T30860 T49489 arg1Of and,As
R58029 T67675 T49489 arg2Of developed,As
R93288 T65899 T30681 arg1Of number,an
R96396 T65899 T53669 arg1Of number,increasing
R95930 T65899 T82409 arg1Of number,of
R36722 T43282 T82409 arg2Of candidates,of
R26921 T40050 T57413 arg2Of measure,be
R49726 T40050 T41872 arg1Of measure,an
R57200 T40050 T99603 arg1Of measure,important
R26078 T40050 T31145 arg1Of measure,of
R16363 T71732 T31145 arg2Of quality,of
R80432 T40708 T53028 arg1Of analysis,Our
R3284 T40708 T82153 arg1Of analysis,glycosylation
R9428 T40708 T61579 arg1Of analysis,of
R38796 T12079 T61579 arg2Of SARS-CoV-2,of
R98841 T40708 T49219 arg1Of analysis,offers
R45319 T74120 T49219 arg2Of benchmark,offers
R63790 T74120 T94729 arg1Of benchmark,a
R15980 T74120 T57933 arg1Of benchmark,detailed
R86101 T43282 T8477 arg1Of candidates,glycoprotein-based
R66613 T43282 T94196 arg1Of candidates,vaccine
R16897 T65899 T96948 arg1Of number,are
R82168 T67675 T96948 arg2Of developed,are
R10910 T65899 T96900 arg1Of number,being
R92826 T67675 T96900 arg2Of developed,being
R86760 T65899 T67675 arg2Of number,developed
R21041 T30860 T62659 arg1Of and,","
R72543 T66124 T20755 arg1Of analysis,their
R95637 T66124 T47361 arg1Of analysis,detailed
R27591 T66124 T51541 arg1Of analysis,glycan
R37520 T66124 T40599 arg1Of analysis,offers
R93896 T34862 T40599 arg2Of route,offers
R77975 T34862 T90463 arg1Of route,a
R28753 T34862 T97151 arg1Of route,for
R77292 T93438 T97151 arg2Of comparing,for
R96457 T61238 T93438 arg2Of integrity,comparing
R2384 T61238 T16844 arg1Of integrity,immunogen
R40732 T40599 T30860 arg1Of offers,and
R10200 T99893 T30860 arg2Of be,and
R74524 T66124 T24785 arg1Of analysis,will
R59298 T99893 T24785 arg2Of be,will
R40051 T99893 T90065 arg1Of be,also
R93934 T66124 T99893 arg1Of analysis,be
R30814 T50945 T99893 arg2Of important,be
R67093 T66124 T50945 arg1Of analysis,important
R11044 T90334 T69841 arg1Of monitor,to
R75058 T99893 T69841 modOf be,to
R22057 T90334 T29169 arg1Of monitor,as
R24618 T70120 T29169 arg2Of scaled,as
R58845 T2806 T25038 arg1Of processes,manufacturing
R30149 T2806 T74292 arg1Of processes,are
R24529 T70120 T74292 arg2Of scaled,are
R83780 T2806 T70120 arg2Of processes,scaled
R35041 T70120 T94082 arg1Of scaled,for
R98113 T10017 T94082 arg2Of use,for
R52389 T10017 T25098 arg1Of use,clinical
R83893 T79926 T12304 arg1Of profiling,Glycan
R66210 T79926 T48513 arg1Of profiling,will
R26895 T57413 T48513 arg2Of be,will
R24135 T57413 T46336 arg1Of be,therefore
R57157 T57413 T92867 arg1Of be,also
R43677 T79926 T57413 arg1Of profiling,be
R62692 T71732 T69406 arg1Of quality,antigen
R10863 T57413 T75814 arg1Of be,in
R45411 T83900 T75814 arg2Of manufacture,in
R70201 T83900 T39084 arg1Of manufacture,the
R79488 T83900 T63349 arg1Of manufacture,of
R72239 T20226 T63349 arg2Of kits,of
R19751 T20226 T35288 arg1Of kits,serological
R47211 T20226 T45219 arg1Of kits,testing
R81689 T63904 T97760 arg1Of Last,","
R97761 T63904 T65795 arg1Of Last,with
R18067 T81020 T65795 arg2Of advent,with
R31431 T81020 T65559 arg1Of advent,the
R3053 T81020 T37516 arg1Of advent,of
R63823 T21690 T37516 arg2Of vaccines,of
R8849 T21690 T28720 arg1Of vaccines,nucleotide-based
R89620 T53107 T20374 arg1Of be,","
R77602 T43342 T66422 arg1Of understand,it
R4730 T43342 T36320 arg1Of understand,will
R96740 T53107 T36320 arg2Of be,will
R94453 T43342 T53107 arg1Of understand,be
R47672 T18553 T53107 arg2Of important,be
R2508 T43342 T18553 arg1Of understand,important
R39101 T43342 T20438 arg1Of understand,to
R65787 T63904 T43342 arg2Of Last,understand
R79548 T53107 T90541 arg1Of be,how
R24143 T62450 T90541 arg2Of affect,how
R42098 T13791 T45086 arg1Of mechanisms,those
R76155 T13791 T83637 arg1Of mechanisms,delivery
R87771 T13791 T62450 arg1Of mechanisms,affect
R80250 T3133 T62450 arg2Of and,affect
R98864 T3133 T67741 arg1Of and,immunogen
R27216 T75860 T3133 arg1Of processing,and
R23306 T84057 T3133 arg2Of presentation,and

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T84 183-195 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925
T85 569-579 Body_part denotes nucleotide http://purl.org/sig/ont/fma/fma82740

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T117 183-195 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089
T118 416-422 Chemical denotes Glycan http://purl.obolibrary.org/obo/CHEBI_18154
T119 569-579 Chemical denotes nucleotide http://purl.obolibrary.org/obo/CHEBI_36976

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T67 30-40 Species denotes SARS-CoV-2 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T101 0-155 Sentence denotes Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site-specific glycan signatures characteristic of a natively folded trimeric spike.
T102 156-415 Sentence denotes As an increasing number of glycoprotein-based vaccine candidates are being developed, their detailed glycan analysis offers a route for comparing immunogen integrity and will also be important to monitor as manufacturing processes are scaled for clinical use.
T103 416-543 Sentence denotes Glycan profiling will therefore also be an important measure of antigen quality in the manufacture of serological testing kits.
T104 544-706 Sentence denotes Last, with the advent of nucleotide-based vaccines, it will be important to understand how those delivery mechanisms affect immunogen processing and presentation.

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T49 30-40 Disease denotes SARS-CoV-2 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
541 149-154 Gene denotes spike Gene:43740568
542 30-40 Species denotes SARS-CoV-2 Tax:2697049
543 86-92 Chemical denotes glycan MESH:D011134
544 257-263 Chemical denotes glycan MESH:D011134
545 416-422 Chemical denotes Glycan MESH:D011134

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T2450 183-195 Protein denotes glycoprotein https://www.uniprot.org/uniprot/Q9QSP1|https://www.uniprot.org/uniprot/Q9QJT6|https://www.uniprot.org/uniprot/Q9JGT4|https://www.uniprot.org/uniprot/Q9IPJ6|https://www.uniprot.org/uniprot/Q9DIC6|https://www.uniprot.org/uniprot/Q91DS0|https://www.uniprot.org/uniprot/Q91C28|https://www.uniprot.org/uniprot/Q8QQA2|https://www.uniprot.org/uniprot/Q8QPE5|https://www.uniprot.org/uniprot/Q8QPE4|https://www.uniprot.org/uniprot/Q8QPE3|https://www.uniprot.org/uniprot/Q8JTH0|https://www.uniprot.org/uniprot/Q8BDV6|https://www.uniprot.org/uniprot/Q8B6J6|https://www.uniprot.org/uniprot/Q8B0I1|https://www.uniprot.org/uniprot/Q8B0H6|https://www.uniprot.org/uniprot/Q8B0H1|https://www.uniprot.org/uniprot/Q89669|https://www.uniprot.org/uniprot/Q85213|https://www.uniprot.org/uniprot/Q82706|https://www.uniprot.org/uniprot/Q82683|https://www.uniprot.org/uniprot/Q82020|https://www.uniprot.org/uniprot/Q787B5|https://www.uniprot.org/uniprot/Q77SK0|https://www.uniprot.org/uniprot/Q77N36|https://www.uniprot.org/uniprot/Q76G52|https://www.uniprot.org/uniprot/Q75T09|https://www.uniprot.org/uniprot/Q6X1D5|https://www.uniprot.org/uniprot/Q6X1D1|https://www.uniprot.org/uniprot/Q6TYA0|https://www.uniprot.org/uniprot/Q6E0W7|https://www.uniprot.org/uniprot/Q66T62|https://www.uniprot.org/uniprot/Q5VKP3|https://www.uniprot.org/uniprot/Q5VKN9|https://www.uniprot.org/uniprot/Q5K2K4|https://www.uniprot.org/uniprot/Q5IX93|https://www.uniprot.org/uniprot/Q5IX92|https://www.uniprot.org/uniprot/Q5IX91|https://www.uniprot.org/uniprot/Q5IX90|https://www.uniprot.org/uniprot/Q5IX89|https://www.uniprot.org/uniprot/Q5IX88|https://www.uniprot.org/uniprot/Q5IX87|https://www.uniprot.org/uniprot/Q5GA86|https://www.uniprot.org/uniprot/Q58FH1|https://www.uniprot.org/uniprot/Q4VKV3|https://www.uniprot.org/uniprot/Q4F900|https://www.uniprot.org/uniprot/Q49LL3|https://www.uniprot.org/uniprot/Q49IU2|https://www.uniprot.org/uniprot/Q49IU1|https://www.uniprot.org/uniprot/Q49IT9|https://www.uniprot.org/uniprot/Q49IT8|https://www.uniprot.org/uniprot/Q49AV0|https://www.uniprot.org/uniprot/Q0GBY1|https://www.uniprot.org/uniprot/Q0GBX6|https://www.uniprot.org/uniprot/Q08089|https://www.uniprot.org/uniprot/P32595|https://www.uniprot.org/uniprot/P32550|https://www.uniprot.org/uniprot/P19462|https://www.uniprot.org/uniprot/P16288|https://www.uniprot.org/uniprot/P15199|https://www.uniprot.org/uniprot/P13180|https://www.uniprot.org/uniprot/P0C572|https://www.uniprot.org/uniprot/P08667|https://www.uniprot.org/uniprot/P08163|https://www.uniprot.org/uniprot/P07923|https://www.uniprot.org/uniprot/P04884|https://www.uniprot.org/uniprot/P04883|https://www.uniprot.org/uniprot/P04882|https://www.uniprot.org/uniprot/P03524|https://www.uniprot.org/uniprot/P03522|https://www.uniprot.org/uniprot/O92284|https://www.uniprot.org/uniprot/O56677|https://www.uniprot.org/uniprot/O10236|https://www.uniprot.org/uniprot/J7HBH4|https://www.uniprot.org/uniprot/D8V075|https://www.uniprot.org/uniprot/A7WNB3|https://www.uniprot.org/uniprot/A4UHQ6|https://www.uniprot.org/uniprot/A4UHQ1|https://www.uniprot.org/uniprot/A3RM22|https://www.uniprot.org/uniprot/A3F5R8|https://www.uniprot.org/uniprot/A3F5R3|https://www.uniprot.org/uniprot/A3F5Q8|https://www.uniprot.org/uniprot/A3F5N3|https://www.uniprot.org/uniprot/A3F5M3|https://www.uniprot.org/uniprot/A3F5L8

LitCovid-sample-PD-GO-BP-0

Id Subject Object Predicate Lexical cue
T40 4-17 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation

LitCovid-sample-GO-BP

Id Subject Object Predicate Lexical cue
T38 4-17 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T46 4-17 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T101 0-155 Sentence denotes Our glycosylation analysis of SARS-CoV-2 offers a detailed benchmark of site-specific glycan signatures characteristic of a natively folded trimeric spike.
T102 156-415 Sentence denotes As an increasing number of glycoprotein-based vaccine candidates are being developed, their detailed glycan analysis offers a route for comparing immunogen integrity and will also be important to monitor as manufacturing processes are scaled for clinical use.
T103 416-543 Sentence denotes Glycan profiling will therefore also be an important measure of antigen quality in the manufacture of serological testing kits.
T104 544-706 Sentence denotes Last, with the advent of nucleotide-based vaccines, it will be important to understand how those delivery mechanisms affect immunogen processing and presentation.

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
541 149-154 Gene denotes spike Gene:43740568
542 30-40 Species denotes SARS-CoV-2 Tax:2697049
543 86-92 Chemical denotes glycan MESH:D011134
544 257-263 Chemical denotes glycan MESH:D011134
545 416-422 Chemical denotes Glycan MESH:D011134